Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03). [electronic resource] by
- Koeberle, D
- Ruhstaller, T
- Jost, L
- Pagani, O
- Zaman, K
- von Moos, R
- Oehlschlegel, C
- Crowe, S
- Pilop, C
- Thuerlimann, B
Producer: 20120227
In:
Endocrine-related cancer vol. 18
Availability: No items available.
|
|
19.
|
Cost of skeletal complications from bone metastases in six European countries. [electronic resource] by
- Pereira, J
- Body, J-J
- Gunther, O
- Sleeboom, H
- Hechmati, G
- Maniadakis, N
- Terpos, E
- Acklin, Y P
- Finek, J
- von Moos, R
Producer: 20170626
In:
Journal of medical economics vol. 19
Availability: No items available.
|
|
20.
|
Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort. [electronic resource] by
- Cathomas, R
- Klingbiel, D
- Geldart, T R
- Mead, G M
- Ellis, S
- Wheater, M
- Simmonds, P
- Nagaraj, N
- von Moos, R
- Fehr, M
Producer: 20151116
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|